Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 4.7B | 4.4B | 4.2B | 3.9B |
| Cost of revenue | 2.4B | 2.3B | 2.2B | 2.0B |
| Gross profit | 2.3B | 2.1B | 2.0B | 1.8B |
| Operating expense | ||||
| Research & development | 525.9M | 494.9M | 495.4M | 497.8M |
| Selling general and admin | 226.0M | 244.2M | 243.1M | 216.5M |
| Other operating expenses | — | — | — | — |
| Operating income | 1.6B | 1.3B | 1.3B | 1.1B |
| Non operating interest income | ||||
| Income | 50.6M | 57.6M | 68.4M | 66.0M |
| Expense | 45.2M | 45.3M | 44.9M | 46.4M |
| Other income expense | -30.5M | 2.0M | 6.6M | 9.0M |
| Pretax income | 1.5B | 1.3B | 1.3B | 1.2B |
| Tax provision | 206.1M | 157.1M | 177.8M | 134.1M |
| Net income | 1.3B | 1.2B | 1.1B | 1.0B |
| Basic EPS | 1.0 | 0.9 | 0.9 | 0.8 |
| Diluted EPS | 1.0 | 0.9 | 0.9 | 0.8 |
| Basic average shares | 1.3B | 1.3B | 1.3B | 1.3B |
| Diluted average shares | 1.3B | 1.3B | 1.3B | 1.3B |
| EBITDA | 1.7B | 1.5B | 1.4B | 1.3B |
| Net income from continuing op. | 1.3B | 1.2B | 1.1B | 1.0B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |